Kestra Medical Technologies, Ltd.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 89.4% | 86.1% | 67.1% | 60.4% | 56.6% | 55.7% | 54.3% | 49.4% | 47.4% | 45.2% | 43.5% | 46.1% | |
| – | 10.6% | 13.9% | 32.9% | 39.6% | 43.4% | 44.3% | 45.7% | 50.6% | 52.6% | 54.8% | 56.5% | 53.9% | |
| – | 45.1% | 38.0% | 26.6% | 23.9% | 22.2% | 31.3% | 20.7% | 21.6% | 20.2% | 19.7% | 21.9% | 20.9% | |
| – | 206.5% | 178.3% | 150.4% | 145.9% | 157.7% | 292.8% | 174.1% | 169.7% | 173.9% | 172.5% | 156.1% | 167.5% | |
| – | 251.6% | 216.3% | 177.1% | 169.7% | 179.9% | 324.1% | 194.8% | 191.4% | 194.2% | 192.1% | 178.1% | 188.4% | |
| – | -241.0% | -202.4% | -144.2% | -130.1% | -136.5% | -279.8% | -149.1% | -140.7% | -141.6% | -137.4% | -121.6% | -134.5% | |
| – | 19.9% | 19.2% | 14.7% | 9.5% | 11.8% | 10.2% | 9.9% | 8.4% | 7.7% | 6.4% | 6.2% | 7.1% | |
| – | -261.0% | -221.9% | -158.9% | -140.1% | -144.1% | -296.0% | -133.2% | -145.1% | -139.0% | -134.9% | -142.2% | -140.1% | |
| – | 0.2% | -0.3% | 0.1% | 0.1% | 0.1% | 0.6% | 0.2% | 0.2% | 0.1% | 0.7% | 0.2% | 0.3% | |
| – | -261.2% | -221.6% | -155.6% | -138.5% | -142.5% | -302.1% | -133.3% | -145.3% | -139.2% | -135.6% | -142.3% | -140.4% | |
| – | -200.4% | -167.8% | -125.7% | -117.9% | -119.7% | -275.1% | -112.8% | -126.2% | -123.2% | -175.0% | -121.6% | -137.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.